CRUK funding for research into earlier detection of relapse in people with multiple myeloma
9 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
New vaccines that aim to prevent cancer: Starting the conversation
28 March 2025
Join us for a joint event from the Centre for Personalised Medicine (CPM) & Oxford Centre for Cancer Early Detection and Prevention (OxCODE) on Monday 2nd June 2025.
Daily physical activity, even at light intensities, linked to lower cancer risk
28 March 2025
A study led by Oxford researchers has found that the number of steps taken daily may be more important for lowering cancer risk than the intensity of activity.
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
25 March 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
New biopsy technique found to improve prostate cancer detection
25 March 2025
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 March 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.
Dr Parinaz Mehdipour awarded CRUK Early Detection and Diagnosis Primer Award
4 March 2025
The funded research aims to identify circular RNA biomarkers for the early detection of normal colon cell transformation into precancerous and colorectal cancer states.
Bowel cancer prediction test for IBD patients 90% accurate
4 February 2025
OxCODE researchers have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Increased calcium and dairy intake lower risk of bowel cancer by nearly a fifth
8 January 2025
In the largest study to date into the link between diet and bowel cancer, Oxford researchers have found that an additional 300mg of calcium each day is associated with a 17% decrease in the risk of colorectal cancers.
Oxford researchers develop blood test to enable early detection of multiple cancers
8 January 2025
Oxford University researchers have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Oxford Centre for Cancer Early Detection and Prevention celebrates 5 years at its 2024 Symposium
3 January 2025
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford’s most successful cancer early detection and prevention programmes.
Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
8 November 2024
Research from Professor Julia Hippisley-Cox shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas, with important implications for NHS screening.
OxCODE researchers at the Early Detection of Cancer Conference 2024
25 October 2024
Oxford’s early detection research was featured at this annual event.
Oxford Liver Cancer Centre of Excellence (OLivE) launched
24 October 2024
Oxford Cancer announces the launch of the Oxford LIVer cancer centre of Excellence (OLivE) to improve outcomes for liver cancer patients.
OxCODE funding scheme awards 2024
22 October 2024
Congratulations to I-Jun Lau, Dimitris Vavoulis and their collaborators who have been awarded funding in the fifth round of the OxCODE Funding Scheme.
UK cancer registry data is as accurate and timely as on-site trial data, new study shows
15 October 2024
OxCODE researchers report that cancer data collected by national cancer registries is comparable to the data gathered directly by researchers in clinical studies. This could make cancer research much easier and less expensive in the future.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from Oxford has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
OxCODE travel award winner featured by Cancer Research UK
12 September 2024
Dr Zhe Huang talks about his work on investigating the proteomic profiles of prostate cancer, his OxCODE-funded trip to Boston and the story behind his early career